In Europe, the pandemic triggered in 2020 by the SARS-CoV-2 coronavirus is now largely under control. But why this virus is able to spread so efficiently remains unclear. A team of researchers led by ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
Scientists used fluorescence microscopy to visualize human ACE2 proteins expressed on mouse cells after incubating the cells with fluorescently labeled SARS-CoV-2 spike protein (green). Left: a view ...
The over-the-counter antihistamine azelastine works against a range of respiratory infections, including the flu and RSV, ...
Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback